Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.3.3 to v3.3.4, a minor metadata change with no impact on study data or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now includes a Locations section with North Carolina; the previous North Carolina Locations entry and HHS Vulnerability Disclosure were removed, and the revision was updated to v3.3.3.SummaryDifference0.3%

- Check50 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedA site-wide notice about government funding and potential delays in updates has been removed. The core study information on the page remains unchanged.SummaryDifference0.4%

- Check72 days agoChange DetectedThe screenshots show layout and formatting adjustments to the study record page with no changes to the core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference6%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.